BDL lands ₹1,348 cr order; IRCTC loses CMD

BDL landed a ₹1,348 crore missile order from HAL, a single contract worth over 2.6% of its market cap. This reverses a 73% revenue decline and gives substance to a 120x P/E valuation. The domestic nature and state-owned counterparty ensure near-zero collection risk. The open question is whether this is a one-off or the start of a sustained order pipeline.

IRCTC's CMD Sanjay Kumar Jain resigned suddenly, leaving a ₹41,484 crore market cap PSU without a permanent leader. This comes as the company pivots to volume-driven growth under a new 30% EBITDA margin target. A prolonged leadership vacuum could slow execution and governance continuity. The government's appointment speed is the next test.

Equitas SFB cleared a ₹1,250 crore QIP, 14% of market cap, alongside a ₹500 crore NCD plan. For a bank with a trailing ROE of 2.5% and P/E of 86x, this is a material equity raise that will dilute near-term earnings. Proceeds could fund growth or shore up capital adequacy. The next test is deployment clarity and margin recovery.

CleanMax backed five SPVs with ₹474 crore in guarantees, a contingent liability equal to 25% of revenue. This supports the aggressive capacity build visible in recent wins like the 900 MW Meta deal and 160 MW Gujarat Alkalies project. With a debt-equity ratio of 3.1x, any P&L stress will be closely watched. The guarantees signal execution confidence but add balance sheet risk.

Rashi Peripherals bought 67% of VDA Infosolutions for ₹368.5 crore, or 7.4% of its market cap. VDA brings cloud and cybersecurity capabilities but its revenue has been declining. The deal shifts Rashi from pure distribution to enterprise solutions, a large enough bet to require model revisions. Integration success will determine whether the premium paid was justified.

Hubtown shareholders approved a merger that unlocks a ₹6,000 crore super-luxury Bandra project, seven times FY26 revenue. The 42:1 exchange ratio means heavy dilution, but the revenue potential justifies the bet. NCLT clearance is the next gate; project delivery will test execution against guidance.

Bansal Wire's promoter will sell 2.99% worth ₹148 crore in the open market to meet minimum public shareholding norms. This is compliance-driven, not distress, but the supply overhang over two months could pressure the stock. Post-sale, the promoter group will be at the 75% cap, so no further dilution is needed.

Man Infra got the go-ahead for a ₹2,000 crore luxury project in Tardeo, with an attributable value of ₹1,010 crore, or 24% of market cap. For a company with trailing revenue down 50.5%, this approval adds meaningful forward pipeline. Launch visibility and execution will determine whether this reverses the revenue decline.

MSP Steel's promoters spent ₹55 crore in open-market purchases over a month, lifting their stake to 45.12%. This is a rare insider vote of confidence in a small-cap steelmaker with a ₹500 crore expansion plan. The buying comes after a dramatic profit swing and suggests management sees value above current levels.

GTPL Hathway bought ACT's cable TV business for ₹36 crore, adding 600,000 subscribers and ₹164 crore in revenue, or 4.4% of its own top line. The deal diversifies geography and recovers lost subscribers at a modest outlay. For a micro-cap with declining profitability, this is a strategic bolt-on that needs integration discipline.

Bodhi Tree Multimedia won an Assam government mandate for a digital content platform, a long-term state contract for a ₹113 crore market cap company. This opens a recurring government revenue stream and could become a replicable model for other states. The order provides revenue visibility beyond the current IP-driven turnaround.

Admach Systems landed a ₹5 crore steel-sector order, pushing its order book to ₹81.71 crore, exceeding annual revenue. For a ₹205 crore market cap company, this extends earnings visibility well into FY27. The repeat steel business suggests sustained demand for specialized equipment, reducing execution risk.

Virgo Global's promoter sold 10.6% of the company in a single open-market trade, a massive stake dump for a ₹6.7 crore market cap entity. The company already has minimal revenue and shrinking capital. This is the loudest possible signal of lost insider conviction, and the stock could face further pressure.

Bacil Pharma's largest non-promoter shareholder cut her stake by 7.1% in two days, adding to a series of exits. The company has zero operating revenue and a ₹60 crore market cap based on speculation. Multiple substantial holders selling in quick succession raises existential questions about the remaining shareholder base.